Your browser doesn't support javascript.
loading
Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus.
Hasni, Sarfaraz; Gupta, Sarthak; Davis, Michael; Poncio, Elaine; Temesgen-Oyelakin, Yenealem; Joyal, Elizabeth; Fike, Alice; Manna, Zerai; Auh, Sungyoung; Shi, Yinghui; Chan, Diana; Carlucci, Philip; Biehl, Ann; Dema, Barbara; Charles, Nicolas; Balow, James E; Waldman, Meryl; Siegel, Richard M; Kaplan, Mariana J; Rivera, Juan.
Afiliação
  • Auh S; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland.
  • Biehl A; Clinical Center, NIH, Bethesda, Maryland.
  • Balow JE; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland.
  • Waldman M; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland.
  • Kaplan MJ; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
  • Rivera J; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
Arthritis Rheumatol ; 71(7): 1135-1140, 2019 07.
Article em En | MEDLINE | ID: mdl-30597768
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Omalizumab / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Omalizumab / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2019 Tipo de documento: Article